Skip to main content

Table 2 Relation between SATB2-AS1 expression and clinicopathological characteristics of BC patients

From: RETRACTED ARTICLE: Long non-coding RNA SATB2-AS1 inhibits microRNA-155-3p to suppress breast cancer cell growth by promoting breast cancer metastasis suppressor 1-like

Clinicopathological characteristics n SATB2-AS1 expression P
Low expression (n = 66) High expression (n = 65)
Age (year)     0.379
 ≥ 51 55 25 30  
 < 51 76 41 35  
Menopause     0.862
 No 61 30 31  
 Yes 70 36 34  
LNM     0.002
 No 58 20 38  
 Yes 73 46 27  
Tumor diameter     0.003
 < 2 cm 46 15 31  
 ≥ 2 cm 85 51 34  
TNM stage     0.008
 I–II 73 29 44  
 III–IV 58 37 21  
Histological grade     0.138
 G1 27 11 16  
 G2 68 38 30  
 G3 36 17 19  
Estrogen receptor
 + 58 23 35 0.029
 – 73 43 30  
Progesterone receptor
 + 61 24 37 0.018
 – 70 42 28  
HER2 status
 – 72 47 35 0.337
 + 59 29 30  
  1. BC breast cancer, SATB2-AS1 antisense transcript of SATB2 protein, LNM lymph node metastasis, TNM tumor, node and metastasis
\